Search - tctmd.com

Displaying 201 - 220 of 1423

Sort: Relevancy | Date

Presentation TCT 2017

Cre8: Novel Attributes and Clinical Trial Program Update

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Alaide Chieffo

November 01, 2017

Presentation TCT 2017

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Presenter: Bernard Prendergast, Brian K. Whisenant, Eric Van Belle

November 01, 2017

Presentation TCT 2017

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

Presenter: Mitchell W. Krucoff, Chaim S. Lotan, Robert A. Byrne

November 01, 2017

Presentation TCT 2017

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

Presenter: Bernard Prendergast, Brian K. Whisenant

November 01, 2017

Presentation TCT 2017

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Presenter: Robert A. Harrington, Gregg W. Stone, Olivier Varenne

November 01, 2017

Presentation TCT 2017

Identifying Optimal Patients for Minimalist TAVR Clinical and Anatomic Guidelines

Presenter: Charles J. Davidson, Mathew Williams, Ruby Satpathy

November 01, 2017

Presentation TCT 2017

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Presenter: Charles J. Davidson, Mathew Williams, Julia Seeger

November 01, 2017

Presentation TCT 2017

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Saami K Yazdani

November 01, 2017

Presentation TCT 2017

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Presenter: Charles J. Davidson, Mathew Williams, Albert Markus Kasel

November 01, 2017

Presentation TCT 2017

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Presenter: Charles J. Davidson, Mathew Williams, Daniel J. Blackman

November 01, 2017

Presentation TCT 2017

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

Presenter: Charles J. Davidson, Mathew Williams, Luis Nombela-Franco

November 01, 2017

News Conference News TCT 2017

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

Shelley Wood

November 01, 2017

Presentation TCT 2017

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Costantino Del Giudice

November 01, 2017

Presentation TCT 2017

Clinical Pearls in: AAA Diagnosis and Treatment

Presenter: William A. Gray, Sahil A. Parikh, D. Christopher Metzger

November 01, 2017

Presentation TCT 2017

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Presenter: Mahmood K. Razavi, Krishna J. Rocha-Singh, Piotr P. Buszman

November 01, 2017

Presentation TCT 2017

Clinical Pearls in: VTE/PE Diagnosis and Treatment

Presenter: William A. Gray, Sahil A. Parikh, Jay S. Giri

November 01, 2017

Presentation TCT 2017

How to Manage a Stroke After TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Stephen R. Ramee

November 01, 2017

Presentation TCT 2017

Clinical Pearls in: CLI Diagnosis and Treatment

Presenter: William A. Gray, Sahil A. Parikh, Mehdi H. Shishehbor

November 01, 2017

Presentation TCT 2017

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

Presenter: Torsten P. Vahl, Mathew Williams, Steven J. Yakubov

November 01, 2017

Presentation TCT 2017

How to Manage Severe LVOT Calcium With TAVR

Presenter: Torsten P. Vahl, Mathew Williams

November 01, 2017

Advertisement

Cre8: Novel Attributes and Clinical Trial Program Update

Bio-Echocardiography to Monitor PVL during and after TAVR: The Case for Point-of-Care Von Willebrand Factor Testing

Yukon and Coroflex ISAR Polymer-Free DES: Clinical Outcomes and Future Directions

Infective Endocarditis after TAVR: Incidence and Clinical Management Decisions

SENIOR: A Randomized Trial of a Bioabsorbable Polymer-Based Metallic DES vs a BMS With Short DAPT in Patients With Coronary Artery Disease Older Than 75 Years

Identifying Optimal Patients for Minimalist TAVR Clinical and Anatomic Guidelines

Recommendations for Cerebral Protection during TAVR Selective vs. Systematic and Special Circumstances

Local Liquid Paclitaxel Delivery Via a Novel Perfusion Catheter: Early Experimental and Clinical Results

Borderline Valve Sizing Dilemmas The In-Between Size and Too Large Annulus

Alternative (Non-femoral) Vascular Access for TAVR Choices and Preferences

Adjunctive Pharmacotherapy after TAVR Settled and Unsettled Issues

VAMPIRE 3: Attenuated Plaque May Signal Benefit of Thrombus Removal in PCI

24-Months Outcomes of PACUS Trial: Randomized Clinical Trial to Compare Ultrasound Enhanced Delivery of Paclitaxel and DEB in Patients With Critical Limb Ischemia and Femoral/Popliteal Disease

Clinical Pearls in: AAA Diagnosis and Treatment

Prospective, Controlled, Clinical Randomized Trial Evaluating Novel, Microcrystalline and Biodegradable Polymer Paclitaxel Coated Balloon for the Treatment of Femoro-popliteal Disease (The BIOPAC trial) - One Year Outcome

Clinical Pearls in: VTE/PE Diagnosis and Treatment

How to Manage a Stroke After TAVR

Clinical Pearls in: CLI Diagnosis and Treatment

How to Manage Conduction Abnormalities and Pacemaker Implantation (temporary and permanent) After TAVR

How to Manage Severe LVOT Calcium With TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content